Thursday, 30 March 2023



LATEST NEWS HIMSU delegation met Sukhvinder Singh Sukhu DC reviews progress of Smart City projects at Sultanpur Lodhi Water Cess not to affect Punjab & Haryana: Sukhvinder Singh Sukhu 'Falahar Grahan Program’ organized at Raj Bhavan CGC Jhanjeri to hold two days CGC Tech-fest Anil Vij met with Vice President of BJP's Mahila Morcha, Nivedita R. Nathoo and other office bearers at Mauritius PIS Trials for residential sports wings from 3rd April: Meet Hayer Agriculture Minister Kuldeep Singh Dhaliwal orders field officers to furnish assessment report of crop damage at the earliest DDC Udhampur Krittika Jyotsna inspects ongoing works of Devika Project Div Com signs MoU with JSW Foundation for development of facilities at Shiv Khori Shrine Pooja Banerjee takes inspiration from Deepika Padukone's 'Cocktail' role NCLAT order in CCI-Google case a cautionary message to all platforms : Rajeev Chandrasekhar WhatsApp working on 15 new durations for disappearing messages Kangana Ranaut says she never succumbed to vanity Mumbai Indians have given me opportunity to showcase myself in different avatar : Rohit Sharma ICC T20I player rankings : Rashid Khan regains top spot among bowlers White Panjab: Gabbar Sangrur To Collaborate With Kaka Ji For An Upcoming Film After Priyanka Chopra Amaal Malik Opens Up About ‘Campism And Powerplay’ In Bollywood State Government Has So Far Given Government Jobs To 27,042 Youth: Bhagwant Mann PMC approves action plan for Silk Samagra-2, recommends for funding Sukhvinder Singh Sukhu wishes Mukesh Agnihotri a speedy recovery


Heart inflammation 11 times higher among the unvaccinated after Covid : Oxford study

Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Liquid Medical Oxygen, Oximeter

Web Admin

Web Admin

5 Dariya News

London , 22 Aug 2022

The risk of myocarditis (inflammation of the heart muscle) in unvaccinated individuals after the Covid infection was at least 11 times higher compared to people who developed the heart condition after receiving a vaccine or booster dose, a detailed analysis of nearly 43 million people, ages 13 and older, has revealed.

Several previous studies and reports from public health agencies, including the US Centers for Disease Control and Prevention (CDC), have highlighted a possible connection and potentially increased risk of myocarditis after receiving an mRNA Covid-19 vaccine, generating considerable scientific, policy and public interest.

"We found that the entire Covid-19-vaccinated population of England during an important 12-month period of the pandemic when the vaccines first became available, the risk of myocarditis following vaccination was quite small compared to the risk of myocarditis after infection," said Martina Patone, a statistician at the University of Oxford.

"This analysis provides important information that may help guide public health vaccine campaigns, particularly since Covid-19 vaccination has expanded in many parts of the world to include children as young as 6 months old," Patone said in the study published in the American Heart Association's peer-reviewed journal Circulation.

In this study, Patone and colleagues evaluated database of Covid-19 vaccinations for all people ages 13 or older who had received at least one dose of the University of Oxford-AstraZeneca vaccine, the Pfizer-BioNTech or the Moderna vaccine between December 1, 2020 and December 15, 2021.

This dataset totaled nearly 43 million people, which included more than 21 million who had received a booster dose of any of the Covid-19 vaccines.Nearly 6 million people tested positive for Covid-19 infection either before or after Covid-19 vaccination during the study period.

The database records were then cross-referenced and matched to the national offices with data on Covid infection, hospital admission and death certificates for the same time period.The analyses found that less than 3,000 people were hospitalised or died with myocarditis during the one-year study period.

People who were infected with Covid-19 before receiving any doses of the vaccines were 11 times more at risk for developing myocarditis during days 1-28 after a Covid-19 positive test, the findings showed."It is important for the public to understand that myocarditis is rare, and the risk of developing myocarditis after a Covid-19 vaccine is also rare.

This risk should be balanced against the benefits of the vaccines in preventing severe infection," said Professor Nicholas Mills, the Butler British Heart Foundation Chair of Cardiology at the University of Edinburgh and a co-author of the paper.It is also crucial to understand who is at a higher risk for myocarditis and which vaccine type is associated with increased myocarditis risk, Mills added.

The SARS-CoV-2 virus continues to shift, and more contagious variants arise."Our hope is that this data may enable a more well-informed discussion on the risk of vaccine-associated myocarditis when considered in contrast to the net benefits of vaccination," said co-author Julia Hippisley-Cox.


Tags: Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Liquid Medical Oxygen , Oximeter



related news




Photo Gallery



Video Gallery



5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2023 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD